People with multiple sclerosis (MS) are far less likely than those without the condition to have the molecular hallmarks of Alzheimer’s disease, according to new research from Washington University School of Medicine in St. Louis.
How retractions get weaponized on social media
Retractions are a sign that science is working as it should. When papers turn out to be flawed, journals typically correct the record to stem
December 24, 2024